Loading...
Loading...
Available on 1 platform
Sign in to view source links and access this dataset
A 2026 systematic review and meta-analysis synthesizes findings from 13 studies encompassing 19 cohorts and 5,304 patients. It quantifies the association between Lung Immune Prognostic Index categories and survival outcomes in renal cell, urothelial, and prostate cancers. The study provides hazard ratios for overall and progression-free survival across different risk groups.
Data is presented in a DOCX document format (7.0 MB); users must extract numerical results and study metadata from the text and tables for analysis. Licensed under CC BY 4.0.